Global Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market
Medical Equipment

Exploring Key Insights of the Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market: Growth Prospects, Emerging Trends, and Opportunities

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the chronic obstructive pulmonary disease (copd) and asthma devices market size evolved in recent years?

The chronic obstructive pulmonary disease (COPD) and asthma devices market has expanded strongly in recent years. It will grow from $44.95 billion in 2024 to $47.83 billion in 2025, reflecting a compound annual growth rate (CAGR) of 6.4%. The market’s growth is attributed to the increasing elderly population, rising allergies, more government initiatives, more clinical research and trials, and urbanization.

What are the predictions for the chronic obstructive pulmonary disease (copd) and asthma devices market size in the coming years?

The chronic obstructive pulmonary disease (COPD) and asthma devices market is projected to grow to $60.53 billion by 2029 at a 6.1% CAGR. Factors driving this growth include the rising rates of respiratory diseases, increased smoking, environmental pollution, and healthcare spending. Key trends in the forecast period include advancements in technology, smart technology integration, personalized medicine, biologics, and wearable respiratory monitors.

Get your chronic obstructive pulmonary disease (copd) and asthma devices market report here!

https://www.thebusinessresearchcompany.com/report/chronic-obstructive-pulmonary-disease-copd-and-asthma-devices-global-market-report

What key factors are fueling the growth of the chronic obstructive pulmonary disease (copd) and asthma devices market?

The increasing prevalence of respiratory diseases is expected to stimulate the growth of the chronic obstructive pulmonary disease (COPD) and asthma devices market. Respiratory diseases like asthma and COPD are on the rise due to air pollution, smoking, and other environmental factors. Devices for managing these conditions are essential for improving patients’ respiratory health. According to the World Health Organization, COPD is the third leading cause of death globally, contributing to millions of fatalities. The growing prevalence of respiratory diseases is driving the COPD and asthma devices market.

How is the global chronic obstructive pulmonary disease (copd) and asthma devices market divided into key segments?

The chronic obstructive pulmonary disease (COPD) and asthma devices market covered in this report is segmented –

1) By Type: Metered Dose Inhalers, Drug Powder Inhalers, Soft Mist Inhalers, Jet Nebulizers, Ultrasonic Nebulizers, Other Types

2) By Indication: Asthma, Chronic Obstructive Pulmonary Disease

3) By Application: Hospitals, Clinics, Home Care Settings, Research Institutions, Other Applications

4) By End User: Pediatric, Adult, Geriatric

Subsegments:

1) By Metered Dose Inhalers: Conventional MDI, Breath-Actuated MDI

2) By Drug Powder Inhalers: Dry Powder Inhalers (DPI), Multi-Dose DPI

3) By Soft Mist Inhalers: Respimat Soft Mist Inhalers, Other Soft Mist Devices

4) By Jet Nebulizers: Pneumatic Nebulizers, Venturi-Type Nebulizers

5) By Ultrasonic Nebulizers: Tabletop Ultrasonic Nebulizers, Portable Ultrasonic Nebulizers

6) By Other Types: Nebulizer Accessories, Spacer Devices

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18298&type=smp

Who are the key firms paving the way for growth in the chronic obstructive pulmonary disease (copd) and asthma devices market?

Major companies operating in the chronic obstructive pulmonary disease (COPD) and asthma devices market are AstraZeneca Plc, Novartis AG, GlaxoSmithKline Plc, 3M Health Care, Boehringer Ingelheim, Royal Philips NV, Teva Pharmaceuticals Industries Ltd., Baxter International Inc., Omron Corporation, Smiths Medical Inc., Recipharm AB, Cipla Ltd., Teleflex Incorporated, Chiesi Farmaceutici SpA, Lincre Holdings Inc., Sunovion Pharmaceuticals Inc., Verona Pharma plc, Drive DeVilbiss Healthcare, Pari Respiratory Equipment Inc., Allied Healthcare Products Inc., Clement Clarke International Ltd., Cohero Health Inc., Pneuma Respiratory Inc., Mundipharma International Ltd.

Which trends are expected to transform the chronic obstructive pulmonary disease (copd) and asthma devices market?

Companies in the chronic obstructive pulmonary disease (COPD) and asthma devices market are integrating digital health features into inhalation devices to support remote monitoring and personalized treatment. These devices deliver medication directly to the lungs. For example, in May 2022, India-based Alkem Laboratories launched the Innohaler, a dry powder inhaler with advanced breath-actuated technology. The device ensures precise medication delivery, optimizes dosage accuracy, and improves patient adherence by offering a user-friendly design that is portable and convenient for patients of all ages.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18298

What regions are contributing significantly to the growth of the chronic obstructive pulmonary disease (copd) and asthma devices market?

North America was the largest region in the chronic obstructive pulmonary disease (COPD) and asthma devices market in 2023. The regions covered in the chronic obstructive pulmonary disease (COPD) and asthma devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Chronic Lower Back Pain Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/chronic-lower-back-pain-global-market-report

Chronic Myeloid Leukemia (CML) Treatment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/chronic-myeloid-leukemia-cml-treatment-global-market-report

Chronic Lymphocytic Leukemia Treatment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/chronic-lymphocytic-leukemia-treatment-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: